Phosphorylated KDR expression in acute leukaemia.

Phosphorylated KDR expression in acute leukaemia.

Bibliographic Details
Main Authors:	Watt, S, Zhang, Y, Pillai, G, Gatter, K, Pezzella, F, Turley, H
Format:	Conference item
Published:	2002

Similar Items

The expression of phosphorylated KDR in haematological malignancies
by: Pillai, G, et al.
Published: (2003)

Phosphorylated VEGFR-2 (pVEFGR-2/pKDR) is over-expressed in and translocates to the nucleus in acute leukemias: Analyses using a novel pKDR antibody.
by: Zhang, Y, et al.
Published: (2003)

Expression of VEGF, its receptors and hypoxia inducible factors in acute myeloblastic leukaemia
by: Zhang, Y, et al.
Published: (2005)

Phosphorylated KDR can be located in the nucleus of neoplastic cells.
by: Blazquez, C, et al.
Published: (2006)

Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation.
by: Giatromanolaki, A, et al.
Published: (2008)

The angiogenic receptor KDR is widely distributed in human tissues and tumours and relocates intracellularly on phosphorylation. An immunohistochemical study.
by: Stewart, M, et al.
Published: (2003)

Expression and cellular localization of vascular endothelial growth factor A and its receptors in acute and chronic leukemias: an immunohistochemical study.
by: Zhang, Y, et al.
Published: (2005)

Expression of phosphorylated (activated) receptors of vascular endothelial growth factor (VEGFR2/KDR) in colorectal cancer
by: Giatromanolaki, A, et al.
Published: (2007)

The expression and cellular localization of phosphorylated VEGFR2 in lymphoma and non-neoplastic lymphadenopathy: an immunohistochemical study.
by: Pillai, G, et al.
Published: (2005)

Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival.
by: Giatromanolaki, A, et al.
Published: (2012)

Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival
by: Giatromanolaki, A, et al.
Published: (2011)

Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer.
by: Giatromanolaki, A, et al.
Published: (2007)

Immunohistological recognition of cyclin D1 expression by non-lymphoid cells among lymphoid neoplastic cells
by: Abdulla, Z, et al.
Published: (2014)

Immunohistological recognition of cyclin D1 expression by non-lymphoid cells among lymphoid neoplastic cells.
by: Abdulla, Z, et al.
Published: (2014)

p53 expression in normal paraffin-embedded tissue using different antibodies and antigen retrieval buffer systems.
by: Pillai, G, et al.
Published: (2003)

The Angiogenesis Regulator and Notch Pathway Activator Delta like Ligand 4 (DII4) Is Widely Expressed by Vascular and Neoplastic Cells in Human Cancer and Relocates to the Nucleus. An Immunohistochemical and In-Situ Hybridization Study
by: Martinez, J, et al.
Published: (2009)

The Angiogenesis Regulator and Notch Pathway Activator Delta like Ligand 4 (DI14) Is Widely Expressed by Vascular and Neoplastic Cells in Human Cancer and Relocates to the Nucleus. An Immunohistochemical and In-Situ Hybridization Study
by: Martinez, J, et al.
Published: (2009)

BNIP3 expression in follicular lymphoma.
by: Sington, J, et al.
Published: (2007)

Reversible p53 expression in lung cancer.
by: Pezzella, F, et al.
Published: (1992)

'Follicular' pattern of bone marrow involvement in lymphocyte-predominant Hodgkin's disease.
by: Pillai, G, et al.
Published: (2003)

EVI1 expression in acute myeloid leukaemia.
by: Langabeer, SE, et al.
Published: (2001)

Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non-Hodgkin's lymphoma.
by: Stewart, M, et al.
Published: (2002)

Nuclear and membrane expression of the angiogenesis regulator Delta Like Ligand 4(DLL4) in normal and malignant human tissues (Histopathology (2009) 54 (598-606))
by: Turley, H, et al.
Published: (2009)

Controlling <it>flk-1/KDR</it> gene expression and angiogenesis
by: Terry Peter, et al.
Published: (2001-03-01)

Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins.
by: Giatromanolaki, A, et al.
Published: (2008)

Malignant plasmacytosis mimicking erythrophagocytosis.
by: Pillai, G, et al.
Published: (2002)

Lesson of the month: Malignant plasmacytosis mimicking erythrophagocytosis
by: Pillai, G, et al.
Published: (2002)

Vascular endothelial growth factor expression in lung cancer.
by: O'Byrne, K, et al.
Published: (1998)

Endothelial β-catenin upregulation and Y142 phosphorylation drive diabetic angiogenesis via upregulating KDR/HDAC9
by: Zhenfeng Chen, et al.
Published: (2024-03-01)

LOSS OF TRAP1 EXPRESSION AS A POSSIBLE MECHANISM BEHIND RECURRENCE RISK IN ADVANCED BREAST CANCER
by: Tan, E, et al.
Published: (2011)

Efficacy of mosquito nets treated with a pyrethroid-organophosphorous mixture against Kdr- and Kdr+ malaria vectors (Anopheles gambiae)
by: Darriet F., et al.
Published: (2003-12-01)

Secondary acute myeloid leukaemia in children treated for acute lymphoblastic leukaemia.
by: Eden, O, et al.
Published: (1998)

JMY protein, a regulator of P53 and cytoplasmic actin filaments, is expressed in normal and neoplastic tissues.
by: Adighibe, O, et al.
Published: (2014)

Expression of Aberrant Markers and its Association with Remission Postinduction Therapy in Acute Lymphoblastic Leukaemia and Acute Myeloid Leukaemia
by: Subbaramaiah Shwetha, et al.
Published: (2021-07-01)

An unusual presentation of diffuse tenosynovial giant cell tumour in the neck.
by: Pillai, G, et al.
Published: (2003)

An unusual presentation of diffuse tenosynovial giant cell tumour in the neck.
by: Pillai, G, et al.
Published: (2003)

Refractory acute monoblastic leukaemia with low hypodiploidy
by: Lum, S.H., et al.
Published: (2014)

Evolution of kdr haplotypes in worldwide populations of Aedes aegypti: Independent origins of the F1534C kdr mutation.
by: Luciano Veiga Cosme, et al.
Published: (2020-04-01)

Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway.
by: Giatromanolaki, A, et al.
Published: (2008)

Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway
by: Giatromanolaki, A, et al.
Published: (2008)